Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock, par value $.0001 per share
-
Shares outstanding
-
6.87M
-
Number of holders
-
44
-
Total 13F shares, excl. options
-
60.1M
-
Shares change
-
-856K
-
Total reported value, excl. options
-
$43.1M
-
Value change
-
-$1.21M
-
Number of buys
-
18
-
Number of sells
-
-33
-
Price
-
$0.72
Significant Holders of Vor Biopharma Inc. - Common Stock, par value $.0001 per share (VOR) as of Q1 2025
62 filings reported holding VOR - Vor Biopharma Inc. - Common Stock, par value $.0001 per share as of Q1 2025.
Vor Biopharma Inc. - Common Stock, par value $.0001 per share (VOR) has 44 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 60.1M shares
.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (39.6M shares), FMR LLC (6.42M shares), 5AM Venture Management, LLC (6.36M shares), VANGUARD GROUP INC (1.94M shares), JOHNSON & JOHNSON (1.07M shares), RENAISSANCE TECHNOLOGIES LLC (701K shares), Sarissa Capital Management LP (508K shares), BlackRock, Inc. (485K shares), GEODE CAPITAL MANAGEMENT, LLC (438K shares), and SUSQUEHANNA INTERNATIONAL GROUP, LLP (384K shares).
This table shows the top 44 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.